InvestorsHub Logo
Followers 137
Posts 3718
Boards Moderated 0
Alias Born 05/10/2006

Re: OTCShotCaller post# 42218

Tuesday, 11/10/2020 7:28:52 PM

Tuesday, November 10, 2020 7:28:52 PM

Post# of 198699
Great post, and we have Covid treatments

About BioClonetics Immunotherapeutics, Inc.
BioClonetics Immunotherapeutics, Inc. is a Dallas Texas biotech company with plans to merge with Enzolytics. BioClonetics has developed a proprietary technology for producing fully human monoclonal antibodies (mAbs) against infectious diseases including HIV, rabies, influenza A, influenza B, tetanus, and diphtheria. Its proprietary methodology for producing fully human monoclonal antibodies may be used to produce therapeutics treatments for many infectious diseases including the Coronavirus.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ENZC News